Search Results - "Nafay, Saba"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes by Shaikh, Sabhita Shabir, Qazi-Arisar, Fakhar Ali, Nafay, Saba, Zaheer, Sidra, Shaikh, Hafeezullah, Azam, Zahid

    Published in World journal of hepatology (27-01-2024)
    “…Metabolic-associated fatty liver disease (MAFLD) is a liver condition marked by excessive fat buildup in the absence of heavy alcohol use. It is primarily…”
    Get full text
    Journal Article
  2. 2

    Assessment of Liver Fibrosis Grading with Non Invasive Scoring Systems Among Non Alcoholic Fatty Liver Disease (NAFLD) Patients by Shaikh, Sabhita Shabir, Nafay, Saba, Reshamwala, Shirin Jalaluddin, Sidra Zaheer, Sajid, Madiha

    Published in Annals of King Edward Medical University (30-03-2024)
    “…Background: The evaluation of degree of liver fibrosis is an important prognostic factor in the management of NAFLD patients. Noninvasive risk stratification…”
    Get full text
    Journal Article
  3. 3

    CHRONIC HEPATITIS C VIRUS: DERMATOLOGICAL MANIFESTATIONS OF INTERFERON PLUS RIBAVIRIN THERAPY IN PATIENTS by Asim, Sadaf Ahmed, Khalid, Abdullah bin, Nafay, Saba, Nisa, Qamar un

    Published in The professional medical journal (13-12-2018)
    “…Objective: To determine the frequency and pattern of dermatological manifestationsin patients receiving interferon and ribavarin for hepatitis C. Patients &…”
    Get full text
    Journal Article
  4. 4

    Treatment profile of hepatitis C patients - a comparison of interferon alpha 2a and 2b treatment regimes by Aziz, Sina, Qamar, Rana, Ahmed, Iftikhar, Imran, Khalid, Masroor, Muhammad, Rajper, Jamila, Nafay, Saba, Noorulain, Wajeeha, Khan, Masood Hameed

    “…To compare the side effects, cost, end treatment response (ETR) and Sustained viral response (SVR) with combination therapy of either interferon alpha 2a or 2b…”
    Get full text
    Journal Article